Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada
Clinical trial NCT03784898 · COMPLETED
Trial details
- NCT number
- NCT03784898
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-08
- Primary completion
- 2019-12-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.